{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:51:49Z","timestamp":1761929509080},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,10,16]],"date-time":"2010-10-16T00:00:00Z","timestamp":1287187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00417-010-1539-y","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T22:30:06Z","timestamp":1287181806000},"page":"421-427","source":"Crossref","is-referenced-by-count":20,"title":["The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats"],"prefix":"10.1007","volume":"249","author":[{"given":"Wenru","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,16]]},"reference":[{"key":"1539_CR1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"1539_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08820530902801478","volume":"24","author":"P Lim","year":"2009","unstructured":"Lim P, Fuchsluger TA, Jurkunas UV (2009) Limbal stem cell deficiency and corneal neovascularization. Semin Ophthalmol 24:139\u2013148","journal-title":"Semin Ophthalmol"},{"key":"1539_CR3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00947088","volume":"235","author":"M Murata","year":"1997","unstructured":"Murata M, Nakagawa M, Takahashi S (1997) Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas. Graefes Arch Clin Exp Ophthalmol 235:584\u2013586","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004170050106","volume":"236","author":"FE Kruse","year":"1998","unstructured":"Kruse FE, Joussen AM, Rohrschneider K, Becker MD, Volcker HE (1998) Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 236:461\u2013466","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","volume":"237","author":"AM Joussen","year":"1999","unstructured":"Joussen AM, Kruse FE, Volcker HE, Kirchhof B (1999) Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol 237:920\u2013927","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004170050330","volume":"237","author":"AM Joussen","year":"1999","unstructured":"Joussen AM, Germann T, Kirchhof B (1999) Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency. Graefes Arch Clin Exp Ophthalmol 237:952\u2013961","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s004170050015","volume":"238","author":"O Klotz","year":"2000","unstructured":"Klotz O, Park JK, Pleyer U, Hartmann C, Baatz H (2000) Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat. Graefes Arch Clin Exp Ophthalmol 238:88\u201393","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","volume":"239","author":"C Cursiefen","year":"2001","unstructured":"Cursiefen C, Wenkel H, Martus P, Langenbucher A, Nguyen NX, Seitz B, Kuchle M, Naumann GO (2001) Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 239:514\u2013521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","volume":"241","author":"PC Wu","year":"2003","unstructured":"Wu PC, Liu CC, Chen CH, Kou HK, Shen SC, Lu CY, Chou WY, Sung MT, Yang LC (2003) Inhibition of experimental angiogenesis of cornea by somatostatin. Graefes Arch Clin Exp Ophthalmol 241:63\u201369","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","volume":"244","author":"M Murata","year":"2006","unstructured":"Murata M, Shimizu S, Horiuchi S, Taira M (2006) Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 244:205\u2013209","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00417-007-0542-4","volume":"245","author":"GA Peyman","year":"2007","unstructured":"Peyman GA, Kivilcim M, Morales AM, DellaCroce JT, Conway MD (2007) Inhibition of corneal angiogenesis by ascorbic acid in the rat model. Graefes Arch Clin Exp Ophthalmol 245:1461\u20131467","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-007-0683-5","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C (2008) Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 246:115\u2013119","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR13","first-page":"264","volume":"104","author":"DT Azar","year":"2006","unstructured":"Azar DT (2006) Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 104:264\u2013302","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1539_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000055693","volume":"33","author":"DH Ma","year":"2001","unstructured":"Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F (2001) Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res 33:353\u2013362","journal-title":"Ophthalmic Res"},{"key":"1539_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","volume":"70","author":"A Kvanta","year":"2000","unstructured":"Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B (2000) Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res 70:419\u2013428","journal-title":"Exp Eye Res"},{"key":"1539_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0945-053X(03)00003-9","volume":"22","author":"NE Sounni","year":"2003","unstructured":"Sounni NE, Janssen M, Foidart JM, Noel A (2003) Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol 22:55\u201361","journal-title":"Matrix Biol"},{"key":"1539_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000071171","volume":"35","author":"DH Ma","year":"2003","unstructured":"Ma DH, Zhang F, Shi W, Yao JY, Hsiao CH, Wu HC, Kim WS, Hao YX, Hwang DG, Chen JK, Tsai RJ (2003) Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res 35:199\u2013207","journal-title":"Ophthalmic Res"},{"key":"1539_CR18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0006-291X(92)91118-A","volume":"188","author":"C Guerin","year":"1992","unstructured":"Guerin C, Laterra J, Masnyk T, Golub LM, Brem H (1992) Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem Biophys Res Commun 188:740\u2013745","journal-title":"Biochem Biophys Res Commun"},{"key":"1539_CR19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","volume":"54","author":"AN Sapadin","year":"2006","unstructured":"Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258\u2013265","journal-title":"J Am Acad Dermatol"},{"key":"1539_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","volume":"19","author":"RA Ralph","year":"2000","unstructured":"Ralph RA (2000) Tetracyclines and the treatment of corneal stromal ulceration: a review. Cornea 19:274\u2013277","journal-title":"Cornea"},{"key":"1539_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(01)00913-8","volume":"132","author":"D Dursun","year":"2001","unstructured":"Dursun D, Kim MC, Solomon A, Pflugfelder SC (2001) Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol 132:8\u201313","journal-title":"Am J Ophthalmol"},{"key":"1539_CR22","first-page":"1569","volume":"30","author":"FR Burns","year":"1989","unstructured":"Burns FR, Stack MS, Gray RD, Paterson CA (1989) Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 30:1569\u20131575","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bjo.2003.025551","volume":"88","author":"VA Smith","year":"2004","unstructured":"Smith VA, Cook SD (2004) Doxycycline-a role in ocular surface repair. Br J Ophthalmol 88:619\u2013625","journal-title":"Br J Ophthalmol"},{"key":"1539_CR24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","volume":"33","author":"L Dan","year":"2008","unstructured":"Dan L, Shi-long Y, Miao-li L, Yong-ping L, Hong-jie M, Ying Z, Xiang-gui W (2008) Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis. Curr Eye Res 33:653\u2013660","journal-title":"Curr Eye Res"},{"key":"1539_CR25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/ICO.0b013e3181605ff9","volume":"27","author":"E Aydin","year":"2008","unstructured":"Aydin E, Kivilcim M, Peyman GA, Esfahani MR, Kazi AA, Sanders DR (2008) Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline. Cornea 27:446\u2013453","journal-title":"Cornea"},{"key":"1539_CR26","first-page":"1625","volume":"37","author":"BM Kenyon","year":"1996","unstructured":"Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37:1625\u20131632","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1099-1263(199807\/08)18:4<233::AID-JAT496>3.0.CO;2-Y","volume":"18","author":"M York","year":"1998","unstructured":"York M, Steiling W (1998) A critical review of the assessment of eye irritation potential using the Draize rabbit eye test. J Appl Toxicol 18:233\u2013240","journal-title":"J Appl Toxicol"},{"key":"1539_CR28","first-page":"2590","volume":"7","author":"S Shan","year":"2001","unstructured":"Shan S, Lockhart AC, Saito WY, Knapp AM, Laderoute KR, Dewhirst MW (2001) The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats. Clin Cancer Res 7:2590\u20132596","journal-title":"Clin Cancer Res"},{"key":"1539_CR29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1582-4934.2006.tb00423.x","volume":"10","author":"K Norrby","year":"2006","unstructured":"Norrby K (2006) In vivo models of angiogenesis. J Cell Mol Med 10:588\u2013612","journal-title":"J Cell Mol Med"},{"key":"1539_CR30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-59745-241-0_20","volume":"467","author":"M Ziche","year":"2009","unstructured":"Ziche M, Morbidelli L (2009) The corneal pocket assay. Methods Mol Biol 467:319\u2013329","journal-title":"Methods Mol Biol"},{"key":"1539_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10456-006-9029-x","volume":"9","author":"S Tong","year":"2006","unstructured":"Tong S, Chen Q, Shan SQ, Dewhirst MW, Yuan F (2006) Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay. Angiogenesis 9:53\u201358","journal-title":"Angiogenesis"},{"key":"1539_CR32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejpb.2007.08.002","volume":"68","author":"K Cal","year":"2008","unstructured":"Cal K, Centkowska K (2008) Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm 68:467\u2013478","journal-title":"Eur J Pharm Biopharm"},{"key":"1539_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","volume":"241","author":"AH El-Kamel","year":"2002","unstructured":"El-Kamel AH (2002) In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm 241:47\u201355","journal-title":"Int J Pharm"},{"key":"1539_CR34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","volume":"50","author":"WL Chen","year":"2009","unstructured":"Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR (2009) Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Invest Ophthalmol Vis Sci 50:1659\u20131665","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR35","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"15","author":"SW Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI (2008) The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 15:e33\u2013e38","journal-title":"Ophthalmology"},{"key":"1539_CR36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","volume":"245","author":"M Erdurmus","year":"2007","unstructured":"Erdurmus M, Totan Y (2007) Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 245:1577\u20131579","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock F, Konig Y, Kruse F, Baier M, Cursiefen C (2008) Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 246:281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00417-008-0976-3","volume":"247","author":"YS Han","year":"2009","unstructured":"Han YS, Lee JE, Jung JW, Lee JS (2009) Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:541\u2013548","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koenig","year":"2009","unstructured":"Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:1375\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR40","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","volume":"247","author":"M Saravia","year":"2009","unstructured":"Saravia M, Zapata G, Ferraiolo P, Racca L, Berra A (2009) Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol 247:1409\u20131416","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","volume":"247","author":"PI Vassileva","year":"2009","unstructured":"Vassileva PI, Hergeldzhieva TG (2009) Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol 247:1701\u20131706","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1539_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/mvre.1997.2056","volume":"55","author":"WJ Lamoreaux","year":"1998","unstructured":"Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, Charles ST (1998) Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 55:29\u201342","journal-title":"Microvasc Res"},{"key":"1539_CR43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737\u2013744","journal-title":"Nat Cell Biol"},{"key":"1539_CR44","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.M201674200","volume":"277","author":"G Hashimoto","year":"2002","unstructured":"Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277:36288\u201336295","journal-title":"J Biol Chem"},{"key":"1539_CR45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.1987.01060020122043","volume":"105","author":"JA Seedor","year":"1987","unstructured":"Seedor JA, Perry HD, McNamara TF, Golub LM, Buxton DF, Guthrie DS (1987) Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits. Arch Ophthalmol 105:268\u2013271","journal-title":"Arch Ophthalmol"},{"key":"1539_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00003226-198401000-00015","volume":"3","author":"HD Perry","year":"1984","unstructured":"Perry HD, Golub LM (1984) Beneficial effect of systemic tetracycline therapy in the treatment of noninfected corneal ulcers. Cornea 3:75","journal-title":"Cornea"},{"key":"1539_CR47","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0161-6420(86)33570-X","volume":"93","author":"HD Perry","year":"1986","unstructured":"Perry HD, Kenyon KR, Lamberts DW, Foulks GN, Seedor JA, Golub LM (1986) Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects. Ophthalmology 93:1320\u20131322","journal-title":"Ophthalmology"},{"key":"1539_CR48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","volume":"83","author":"CS Paiva De","year":"2006","unstructured":"De Paiva CS, Corrales RM, Villarreal AL, Farley WJ, Li DQ, Stern ME, Pflugfelder SC (2006) Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 83:526\u2013535","journal-title":"Exp Eye Res"},{"key":"1539_CR49","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","volume":"47","author":"CS Paiva De","year":"2006","unstructured":"De Paiva CS, Corrales RM, Villarreal AL, Farley W, Li DQ, Stern ME, Pflugfelder SC (2006) Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci 47:2847\u20132856","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1539_CR50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003226-200401000-00020","volume":"23","author":"DU Stone","year":"2004","unstructured":"Stone DU, Chodosh J (2004) Oral tetracyclines for ocular rosacea: an evidence-based review of the literature. Cornea 23:106\u2013109","journal-title":"Cornea"},{"key":"1539_CR51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0161-6420(93)31475-2","volume":"100","author":"WW Culbertson","year":"1993","unstructured":"Culbertson WW, Huang AJ, Mandelbaum SH, Pflugfelder SC, Boozalis GT, Miller D (1993) Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology 100:1358\u20131366","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1539-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1539-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:04Z","timestamp":1559072884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,16]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1539-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,16]]}}}